title: Knee tuberculosis under rituximab therapy for rheumatoid arthritis.
authors.forename: Sébastien
authors.initials: S
authors.lastname: Ottaviani
authors.forename: Joelle
authors.initials: J
authors.lastname: Tiendrebeogo
authors.forename: Laurence
authors.initials: L
authors.lastname: Choudat
authors.forename: Ghislaine
authors.initials: G
authors.lastname: Gill
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Palazzo
authors.forename: Olivier
authors.initials: O
authors.lastname: Meyer
authors.forename: Philippe
authors.initials: P
authors.lastname: Dieudé
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007719:Knee Joint; D000069283:Rituximab; D016896:Treatment Outcome; D014394:Tuberculosis, Osteoarticular / Q000175:diagnosis* / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D028761:Withholding Treatment
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000995:Antitubercular Agents; D014409:Tumor Necrosis Factor-alpha; D000069283:Rituximab